This inventor holds 4 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Merck Sharp + Dohme B.v., Jazz Pharmaceuticals Research UK Limited. Active years: 2015-2026.
Location History:
- Saffron Walden, GB (2015)
- Saffron, GB (2015 - 2018)
Company Filing History:
3 out of 55 
1 out of 23 Years Active: 2015-2026
Title: Paul Stuart Hinchliffe: Innovator in Pharmaceutical Advancements
Introduction
Paul Stuart Hinchliffe is a notable inventor based in Saffron, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on FSH receptor antagonists. With a total of three patents to his name, Hinchliffe's inventions are aimed at addressing critical health issues.
Latest Patents
Hinchliffe's latest patents focus on FSH receptor antagonists, which are compounds designed to inhibit the action of the follicle-stimulating hormone (FSH). These inventions are described by a general formula and include pharmaceutically acceptable salts. The pharmaceutical compositions developed from these compounds can be utilized for the treatment and prevention of endometriosis, pre-menopausal and peri-menopausal hormone-dependent breast cancer, contraception, and the treatment of uterine fibroids and other menstrual-related disorders.
Career Highlights
Hinchliffe is currently associated with Merck Sharp & Dohme B.V., where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions that address significant medical challenges.
Collaborations
Throughout his career, Hinchliffe has collaborated with esteemed colleagues such as Wesley Peter Blackaby and Martin De Kort. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.
Conclusion
Paul Stuart Hinchliffe stands out as a prominent inventor in the pharmaceutical industry, with a focus on innovative treatments for women's health issues. His contributions through patents and collaborations reflect his commitment to advancing medical science and improving patient care.